Business Description
Biora Therapeutics Inc
NAICS : 541714
SIC : 2833
ISIN : US74319F3055
Share Class Description:
FRA:4ZU: Ordinary SharesDescription
Biora Therapeutics Inc is a biotechnology company engaged in developing oral biotherapeutics. Its drug-device combinations could enable new treatment approaches in the delivery of therapeutics in two main areas: Targeted delivery of therapeutics to the site of disease in the gastrointestinal ("GI") tract, which is designed to improve outcomes for patients with Inflammatory Bowel Disease (IBD); and Systemic delivery of biotherapeutics, which are designed to replace injection with needle-free, oral delivery technology.
Financial Strength
1/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Cash-To-Debt | 0.08 | |||||
| Equity-to-Asset | -7.35 | |||||
| Debt-to-Equity | -0.37 | |||||
| Debt-to-EBITDA | -1.42 | |||||
| Piotroski F-Score | 3/9 | |||||
| Altman Z-Score | -109.21 | |||||
| Beneish M-Score | 34.05 | |||||
| WACC vs ROIC | ||||||
Growth Rank
7/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Revenue Growth Rate | -87.3 | |||||
| 3-Year EBITDA Growth Rate | 57.8 | |||||
| 3-Year EPS without NRI Growth Rate | 54.5 | |||||
| 3-Year FCF Growth Rate | 72.9 | |||||
| 3-Year Book Growth Rate | 57.6 | |||||
| Future 3-5Y EPS without NRI Growth Rate | 55.72 | |||||
| Future 3-5Y Total Revenue Growth Rate | 680.76 |
Momentum Rank
1/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 5-Day RSI | 64.61 | |||||
| 9-Day RSI | 57.74 | |||||
| 14-Day RSI | 52.66 | |||||
| 6-1 Month Momentum % | -17.74 | |||||
| 12-1 Month Momentum % | -58.87 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Current Ratio | 0.05 | |||||
| Quick Ratio | 0.05 | |||||
| Cash Ratio | 0.03 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Average Share Buyback Ratio | -131.9 | |||||
| Shareholder Yield % | 3086.23 |
Profitability Rank
1/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Operating Margin % | -6824.33 | |||||
| Net Margin % | -3535.76 | |||||
| FCF Margin % | -5151.76 | |||||
| ROA % | -129.6 | |||||
| ROIC % | -100.29 | |||||
| ROC (Joel Greenblatt) % | -1087.18 |
GF Value Rank
2/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| PS Ratio | 1.86 | |||||
| EV-to-EBIT | -1.35 | |||||
| EV-to-Forward-EBIT | -0.57 | |||||
| EV-to-EBITDA | -1.37 | |||||
| EV-to-Forward-EBITDA | -0.57 | |||||
| EV-to-Revenue | 43.09 | |||||
| EV-to-Forward-Revenue | 7.82 | |||||
| EV-to-FCF | -0.83 | |||||
| Earnings Yield (Greenblatt) % | -74.07 | |||||
| FCF Yield % | -2321.76 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Biora Therapeutics Inc Executives
DetailsAnalyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil €) | 0.823 | ||
| EPS (TTM) (€) | -11.886 | ||
| Beta | 0.31 | ||
| Volatility % | 75.39 | ||
| 14-Day RSI | 52.66 | ||
| 14-Day ATR (€) | 0.022297 | ||
| 20-Day SMA (€) | 5.1 | ||
| 12-1 Month Momentum % | -58.87 | ||
| 52-Week Range (€) | 3.88 - 15.5 | ||
| Shares Outstanding (Mil) | 4.52 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 3 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Biora Therapeutics Inc Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Biora Therapeutics Inc Stock Events
| Event | Date | Price(€) | ||
|---|---|---|---|---|
| No Event Data | ||||
Biora Therapeutics Inc Frequently Asked Questions
What is Biora Therapeutics Inc(FRA:4ZU)'s stock price today?
The current price of FRA:4ZU is €5.10. The 52 week high of FRA:4ZU is €15.50 and 52 week low is €3.88.
When is next earnings date of Biora Therapeutics Inc(FRA:4ZU)?
The next earnings date of Biora Therapeutics Inc(FRA:4ZU) is 2025-03-26 Est..
Does Biora Therapeutics Inc(FRA:4ZU) pay dividends? If so, how much?
Biora Therapeutics Inc(FRA:4ZU) does not pay dividend.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers